Engineering bispecific exosome activators of T cells to target immune checkpoint inhibitor-resistant metastatic melanoma. (nature.com)

Authors: Liu S … Cheng K Journal: Nature Biotechnology Published: 2026-01-05 DOI: https://doi.org/10.1038/s41587-025-02890-8